Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

(2020) Mohd H. Abdul-Aziz et al.   INTENSIVE CARE MEDICINE

Hematologic adverse effects induced by piperacillin–tazobactam: a systematic review of case reports

(2020) Qingqing Wang et al.   International Journal of Clinical Pharmacy

Idiosyncratic Drug-Induced Neutropenia and Agranulocytosis in Elderly Patients

(2020) Noel Lorenzo-Villalba et al.   Journal of Clinical Medicine

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis

(2020) Milo Gatti et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing

(2020) Milo Gatti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review

(2019) Chandra Datta Sumi et al.   CLINICAL PHARMACOKINETICS

Advances in the therapy of bacterial bloodstream infections

(2019) M. Giannella et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

(2019) Taylor M. Patek et al.   DRUG SAFETY

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study

(2019) Milo Gatti et al.   BMC Pharmacology & Toxicology

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

(2018) Jesús Rodríguez-Baño et al.   CLINICAL MICROBIOLOGY REVIEWS

Novel β-lactam/β-lactamase inhibitors versus alternative antibiotics for the treatment of complicated intra-abdominal infection and complicated urinary tract infection: a meta-analysis of randomized controlled trials

(2018) Mengmeng Chen et al.   Expert Review of Anti-Infective Therapy

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems

(2018) E. Raschi et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Renal Dosing of Antibiotics: Are We Jumping the Gun?

(2018) Ryan L Crass et al.   CLINICAL INFECTIOUS DISEASES

Beta-lactam-induced severe neutropaenia: a descriptive study

(2018) Thierry Vial et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Infections by multidrug-resistant Gram-negative Bacteria: what's new in our arsenal and what's in the pipeline?

(2018) Despoina Koulenti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Analysis of a long-term outbreak of XDRPseudomonas aeruginosa: a molecular epidemiological study

(2015) Matthias Willmann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Seizures as adverse events of antibiotic drugs

(2015) Raoul Sutter et al.   NEUROLOGY

Pancreatitis in tigecycline Phase 3 and 4 clinical studies

(2013) P. C. McGovern et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobials and the Risk of Torsades de Pointes

(2010) Elisabetta Poluzzi et al.   DRUG SAFETY